SET - Chronic Pain | SET – The defibrillator for Chronic Pain

Summary
SET solution for chronic pain.

100 million EU sufferers, €300 billion, Age related.

Current solutions do not look at data, biomarkers, or take into consideration the individual differences between patients. With real data from large groups of patients, for the first time we can characterize the autonomic nervous system, which is depreciated in chronic pain patients, and use it to fight chronic pain. With the therapy, we attack the underlying psychological cause for the pain. The SET device allows us to do this efficiently. Using ICT data, we will be able to a real progress on this large social problem. By iterating, continuing to add data, measuring results, and adjusting approaches, we can attack chronic pain and make people pain free.

SET was tested at the University of Marburg with 120 patients that included 2 sham protocols. Of the non-control participants, 100% of fibromyalgia patients became pain free for six months, and 82% at the 12-month follow-up.

The data, which includes all the EKG and blood pressure data from each patient session as well as the patients' initial interview and progress data from the E-learning system, will be uploaded to a MySQL database hosted on a medical grade cloud server. Data mining and analytics software will only have read access and only anonymized access will be available, so that it will not be possible to identify any individual patient.

Patent protection, a highly experienced team, a clear strongly motivated market will make the company successful. In the process many therapy based SMEs will be formed and enhanced.

A real solution for a debilitating social problem which invloves ICT, big data, and job creation.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/729291
Start date: 01-07-2016
End date: 31-10-2016
Total budget - Public funding: 71 429,00 Euro - 50 000,00 Euro
Cordis data

Original description

SET solution for chronic pain.

100 million EU sufferers, €300 billion, Age related.

Current solutions do not look at data, biomarkers, or take into consideration the individual differences between patients. With real data from large groups of patients, for the first time we can characterize the autonomic nervous system, which is depreciated in chronic pain patients, and use it to fight chronic pain. With the therapy, we attack the underlying psychological cause for the pain. The SET device allows us to do this efficiently. Using ICT data, we will be able to a real progress on this large social problem. By iterating, continuing to add data, measuring results, and adjusting approaches, we can attack chronic pain and make people pain free.

SET was tested at the University of Marburg with 120 patients that included 2 sham protocols. Of the non-control participants, 100% of fibromyalgia patients became pain free for six months, and 82% at the 12-month follow-up.

The data, which includes all the EKG and blood pressure data from each patient session as well as the patients' initial interview and progress data from the E-learning system, will be uploaded to a MySQL database hosted on a medical grade cloud server. Data mining and analytics software will only have read access and only anonymized access will be available, so that it will not be possible to identify any individual patient.

Patent protection, a highly experienced team, a clear strongly motivated market will make the company successful. In the process many therapy based SMEs will be formed and enhanced.

A real solution for a debilitating social problem which invloves ICT, big data, and job creation.

Status

CLOSED

Call topic

SMEInst-06-2016-2017

Update Date

27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
H2020-EU.2.1.1.0. INDUSTRIAL LEADERSHIP - ICT - Cross-cutting calls
H2020-SMEINST-1-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-SMEINST-2-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-1-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-SMEINST-2-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.4. Active ageing and self-management of health
H2020-EU.3.1.4.0. Cross-cutting call topics
H2020-SMEINST-1-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-SMEINST-2-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-EU.3.1.6. Health care provision and integrated care
H2020-EU.3.1.6.0. Cross-cutting call topics
H2020-SMEINST-1-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-SMEINST-2-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well